| Authors: |
Frezza V; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy., Fierro C; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy., Gatti E; Department of Experimental Oncology European Institute of Oncology, Milan 20139, Italy., Peschiaroli A; National Research Council of Italy Institute of Translational Pharmacology (IFT-CNR), Rome 00133, Italy., Lena AM; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy., Petruzzelli MA; Istituto Dermopatico dell'Immacolata, IRCCS,, Rome 00163, Italy., Candi E; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy.; Istituto Dermopatico dell'Immacolata, IRCCS,, Rome 00163, Italy., Anemona L; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy., Mauriello A; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy., Pelicci PG; Department of Experimental Oncology European Institute of Oncology, Milan 20139, Italy., Melino G; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy.; Medical Research Council, Toxicology Unit, University of Cambridge, Leicester LE1 9HN, UK., Bernassola F; Department of Experimental Medicine, TOR University of Rome 'Tor Vergata', Rome 00133, Italy. |
